Literature DB >> 25913109

The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans.

Jose A Cortes-Briones1, John D Cahill2, Patrick D Skosnik2, Daniel H Mathalon3, Ashley Williams4, R Andrew Sewell2, Brian J Roach5, Judith M Ford3, Mohini Ranganathan2, Deepak Cyril D'Souza6.   

Abstract

BACKGROUND: Drugs that induce psychosis may do so by increasing the level of task-irrelevant random neural activity or neural noise. Increased levels of neural noise have been demonstrated in psychotic disorders. We tested the hypothesis that neural noise could also be involved in the psychotomimetic effects of delta-9-tetrahydrocannabinol (Δ(9)-THC), the principal active constituent of cannabis.
METHODS: Neural noise was indexed by measuring the level of randomness in the electroencephalogram during the prestimulus baseline period of an oddball task using Lempel-Ziv complexity, a nonlinear measure of signal randomness. The acute, dose-related effects of Δ(9)-THC on Lempel-Ziv complexity and signal power were studied in humans (n = 24) who completed 3 test days during which they received intravenous Δ(9)-THC (placebo, .015 and .03 mg/kg) in a double-blind, randomized, crossover, and counterbalanced design.
RESULTS: Δ(9)-THC increased neural noise in a dose-related manner. Furthermore, there was a strong positive relationship between neural noise and the psychosis-like positive and disorganization symptoms induced by Δ(9)-THC, which was independent of total signal power. Instead, there was no relationship between noise and negative-like symptoms. In addition, Δ(9)-THC reduced total signal power during both active drug conditions compared with placebo, but no relationship was detected between signal power and psychosis-like symptoms.
CONCLUSIONS: At doses that produced psychosis-like effects, Δ(9)-THC increased neural noise in humans in a dose-dependent manner. Furthermore, increases in neural noise were related with increases in Δ(9)-THC-induced psychosis-like symptoms but not negative-like symptoms. These findings suggest that increases in neural noise may contribute to the psychotomimetic effects of Δ(9)-THC. Published by Elsevier Inc.

Entities:  

Keywords:  Cannabinoids; Electroencephalogram; Neural noise; Nonlinear analysis; Psychosis; Tetrahydrocannabinol

Mesh:

Substances:

Year:  2015        PMID: 25913109      PMCID: PMC4627857          DOI: 10.1016/j.biopsych.2015.03.023

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  55 in total

Review 1.  The brainweb: phase synchronization and large-scale integration.

Authors:  F Varela; J P Lachaux; E Rodriguez; J Martinerie
Journal:  Nat Rev Neurosci       Date:  2001-04       Impact factor: 34.870

2.  Canonical correlation analysis applied to remove muscle artifacts from the electroencephalogram.

Authors:  Wim De Clercq; Anneleen Vergult; Bart Vanrumste; Wim Van Paesschen; Sabine Van Huffel
Journal:  IEEE Trans Biomed Eng       Date:  2006-12       Impact factor: 4.538

3.  A theoretically based index of consciousness independent of sensory processing and behavior.

Authors:  Adenauer G Casali; Olivia Gosseries; Mario Rosanova; Mélanie Boly; Simone Sarasso; Karina R Casali; Silvia Casarotto; Marie-Aurélie Bruno; Steven Laureys; Giulio Tononi; Marcello Massimini
Journal:  Sci Transl Med       Date:  2013-08-14       Impact factor: 17.956

4.  The correlation between white-matter microstructure and the complexity of spontaneous brain activity: a difussion tensor imaging-MEG study.

Authors:  Alberto Fernández; Marcos Ríos-Lago; Daniel Abásolo; Roberto Hornero; Juan Alvarez-Linera; Nuria Paul; Fernando Maestú; Tomás Ortiz
Journal:  Neuroimage       Date:  2011-06-12       Impact factor: 6.556

5.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

6.  Schizophrenics have fewer and smaller P300s: a single-trial analysis.

Authors:  J M Ford; P White; K O Lim; A Pfefferbaum
Journal:  Biol Psychiatry       Date:  1994-01-15       Impact factor: 13.382

7.  Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.

Authors:  Deepak Cyril D'Souza; Walid Michel Abi-Saab; Steven Madonick; Kimberlee Forselius-Bielen; Anne Doersch; Gabriel Braley; Ralitza Gueorguieva; Thomas B Cooper; John Harrison Krystal
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

8.  Real-time neural activity and connectivity in healthy individuals and schizophrenia patients.

Authors:  Andreas A Ioannides; Vahe Poghosyan; Jürgen Dammers; Marcus Streit
Journal:  Neuroimage       Date:  2004-10       Impact factor: 6.556

9.  Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations.

Authors:  Stephen M Lawrie; Christian Buechel; Heather C Whalley; Christopher D Frith; Karl J Friston; Eve C Johnstone
Journal:  Biol Psychiatry       Date:  2002-06-15       Impact factor: 13.382

10.  Baseline gamma power during auditory steady-state stimulation in schizophrenia.

Authors:  Kevin M Spencer
Journal:  Front Hum Neurosci       Date:  2012-01-13       Impact factor: 3.169

View more
  11 in total

1.  Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood.

Authors:  Yan Jouroukhin; Xiaolei Zhu; Alexey V Shevelkin; Yuto Hasegawa; Bagrat Abazyan; Atsushi Saito; Jonathan Pevsner; Atsushi Kamiya; Mikhail V Pletnikov
Journal:  Biol Psychiatry       Date:  2018-08-16       Impact factor: 13.382

2.  Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.

Authors:  B A S Reyes; A F Carvalho; P Szot; D J Kalamarides; Q Wang; L G Kirby; E J Van Bockstaele
Journal:  Exp Neurol       Date:  2017-03-21       Impact factor: 5.330

3.  Psychosis-Relevant Effects of Intravenous Delta-9-Tetrahydrocannabinol: A Mega Analysis of Individual Participant-Data from Human Laboratory Studies.

Authors:  Suhas Ganesh; Jose Cortes-Briones; Mohini Ranganathan; Rajiv Radhakrishnan; Patrick D Skosnik; Deepak Cyril D'Souza
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

4.  Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans.

Authors:  Patrick D Skosnik; Mihály Hajós; Jose A Cortes-Briones; Chad R Edwards; Brian P Pittman; William E Hoffmann; Andrew R Sewell; Deepak C D'Souza; Mohini Ranganathan
Journal:  Neuropharmacology       Date:  2018-03-28       Impact factor: 5.250

Review 5.  The early identification of psychosis: can lessons be learnt from cardiac stress testing?

Authors:  Swapnil Gupta; Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2015-11-14       Impact factor: 4.530

6.  Cannabis users exhibit increased cortical activation during resting state compared to non-users.

Authors:  Shikha Prashad; Elizabeth S Dedrick; Francesca M Filbey
Journal:  Neuroimage       Date:  2018-06-09       Impact factor: 6.556

Review 7.  Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.

Authors:  Rafael N Ruggiero; Matheus T Rossignoli; Jana B De Ross; Jaime E C Hallak; Joao P Leite; Lezio S Bueno-Junior
Journal:  Front Pharmacol       Date:  2017-06-21       Impact factor: 5.810

8.  Independent associations and effect modification between lifetime substance use and recent mood disorder diagnosis with household food insecurity.

Authors:  Karen M Davison; Cliff Holloway; Lovedeep Gondara; Anne S Hatcher
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

9.  Cannabis Use: Neurobiological, Behavioral, and Sex/Gender Considerations.

Authors:  Anahita Bassir Nia; Claire Mann; Harsimar Kaur; Mohini Ranganathan
Journal:  Curr Behav Neurosci Rep       Date:  2018-11-10

Review 10.  Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies.

Authors:  Matthew E Sloan; Caroline W Grant; Joshua L Gowin; Vijay A Ramchandani; Bernard Le Foll
Journal:  Acta Pharmacol Sin       Date:  2018-08-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.